Hasil Pencarian - Mark Jacobson

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Low rates of Hepatitis B and Human Immunodeficiency Virus coinfection in rural northern Tanzania

    Low rates of Hepatitis B and Human Immunodeficiency Virus coinfection in rural northern Tanzania oleh Jose D Debes, William M Stauffer, Mark Jacobson, David R Boulware

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Unilateral perniosis (chilblains) following hip arthroplasty

    Unilateral perniosis (chilblains) following hip arthroplasty oleh Brianna J. Lally, BS, Anthony K. Guzman, MD, Yevgeniy Balagula, MD, Michael Dewall, MD, Mark Jacobson, MD

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Long-term maintenance of eosinophilic dermatosis of hematologic malignancy with doxycycline

    Long-term maintenance of eosinophilic dermatosis of hematologic malignancy with doxycycline oleh Karolina Mieczkowska, BS, Alexandra K. Rzepecki, MD, Jack Jacob, DO, Bijal Amin, MD, Mark Jacobson, MD, Beth N. McLellan, MD

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma

    Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma oleh Mathew R. Birnbaum, BS, Michelle W. Ma, MD, Sarah Fleisig, MD, Stuart Packer, MD, Bijal D. Amin, MD, Mark Jacobson, MD, Beth N. McLellan, MD

    Diterbitkan 2017-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol

    Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, sin... oleh Aashna Karbhari, Sherly Mosessian, Kamaxi H. Trivedi, Frank Valla, Mark Jacobson, Mark J. Truty, Nandakumar G. Patnam, Diane M. Simeone, Elcin Zan, Tracy Brennan, Hongli Chen, Phillip H. Kuo, Ken Herrmann, Ajit H. Goenka

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol.

    Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, sin... oleh Aashna Karbhari, Sherly Mosessian, Kamaxi H Trivedi, Frank Valla, Mark Jacobson, Mark J Truty, Nandakumar G Patnam, Diane M Simeone, Elcin Zan, Tracy Brennan, Hongli Chen, Phillip H Kuo, Ken Herrmann, Ajit H Goenka

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68Ga‐PSMA‐11 PET Using Cyclotron‐Produced 68Ga

    PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68Ga‐PSMA‐11 PET Using Cyclotron‐Produced 68Ga oleh Scott M. Thompson, Garima Suman, Michael S. Torbenson, Zong‐Ming E. Chen, Danielle E. Jondal, Anurima Patra, Eric C. Ehman, James C. Andrews, Chad J. Fleming, Brian T. Welch, Anil N. Kurup, Lewis R. Roberts, Kymberly D. Watt, Mark J. Truty, Sean P. Cleary, Rory L. Smoot, Julie K. Heimbach, Nguyen H. Tran, Amit Mahipal, Jun Yin, Tyler Zemla, Chen Wang, Zachary Fogarty, Mark Jacobson, Bradley J. Kemp, Sudhakar K. Venkatesh, Geoffrey B. Johnson, David A. Woodrum, Ajit H. Goenka

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: